Rallybio Corporation - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi RLYB
Rallybio Corporation (RLYB) developments against neonatal thrombocytopenia are undergoing clinical trials supported by a stable liquidity reserve. Operating cash flow before interest and taxes demonstrates profit dynamics, where 0.00 is the current value of the indicator. The pricing power for orphan drugs is maintained by strict FDA control and patent protection, creating insurmountable barriers to entry for new players.
Ringkesan rincian data analitis Rallybio (RLYB)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Rallybio Corporation|RLYB - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Rallybio Corp|RLYB - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Rallybio|RLYB - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Rallybio|Likuiditas cepet rallybio.com
- statistik bathi lan rasio pasar:
RLYB - Penghasilan resik|Bathi resik sing dikarepake Rallybio Corporation|RLYB - Pangali P/E|Rega marang bathi mangsa ngarep Rallybio Corp|RLYB - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Rallybio|RLYB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Rallybio|RLYB - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan rallybio.com|RLYB - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Rallybio Corporation
Ringkesan analitik perusahaan:RLYB (Rallybio Corporation)
This indicator captures the actual cash flow generated by core operations before deducting financial obligations and taxes, reflecting the business's ability to self-fund its expenses. Continuous monitoring of EBITDA allows for an assessment of the financial stability of Rallybio Corporation (RLYB), where the operating flow is primarily driven by grants for the development of innovative drugs for the therapy of rare pathologies.
Pesaing Rallybio Corporation (RLYB)
Haleon Corp (HLN) - Bathi sadurunge bunga, pajak, lan amortisasi|KVUE: Bathi operasional sadurunge ngurangi amortisasi|veronapharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Ligand Pharmaceuticals Incorporated - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|AMRX (Amneal Pharmaceuticals Inc) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Perrigo Corp PRGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alvotech (ALVO)|LQDA (liquidia.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Galapagos GLPG|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ANIP|MannKind Corp. - Bathi operasional EBITDA|AMPH - Bathi operasional EBITDA|Pacira BioSciences (PCRX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SPRY (ars-pharma.com) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Theravance Biopharma, Inc.|Bathi sadurunge mbayar bunga, pajak, lan amortisasi AQST|Bathi operasional sadurunge ngurangi amortisasi SCPH (scPharmaceuticals Inc.)|TECX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi operasional EBITDA TNXP (Tonix Pharmaceuticals)|SXT Pharmaceuticals - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Eupraxia Pharma - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi BioHarvest Sciences, Inc. BHST|Invizyne Technologies, Inc. (EXOZ) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Oramed Pharmaceuticals Inc. (ORMP)|Bathi operasional sadurunge ngurangi amortisasi ENTX|HYFT: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ABVC|Bathi operasional sadurunge ngurangi amortisasi Cumberland Pharmaceuticals Inc CPIX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Quantum BioPharma Limited QNTM|FibroGen Corporation (FGEN) - Bathi sadurunge bunga, pajak, lan amortisasi|TELO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi RANI (Rani Therapeutics)|synergychc.com (SNYR) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi LEXX (Lexaria Bioscience Corp.)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pulmatrix Corp|Bathi sadurunge bunga, pajak, lan amortisasi Pheton PTHL|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Aptorum Group Limited (APM)|LYRA (lyratherapeutics.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA IBO (Impact BioMedical)|Bathi operasional EBITDA TNF Pharmaceuticals Inc. TNFA|YCBD: Bathi operasional sadurunge ngurangi amortisasi|PainReform Corp - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|CYTO: Bathi operasional EBITDA|LIPO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OptiNose|Bathi sadurunge bunga, pajak, lan amortisasi Pieris Pharmaceuticals Inc PIRS|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Procaps Group SA (PROC)|Petros Pharma - Bathi operasional sadurunge amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Qilian International QLI|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SLRN|TFFP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi
